Posted on July 1, 2022
Statement from NEHI Regarding Recent SCOTUS Decision to Overturn Roe v. Wade.
Posted on June 9, 2022
NEHI and Eli Lilly & Company form a Community Focused Research Organization (CFRO) to promote diversity in clinical trial participation.
Posted on May 4, 2022
Two NEHI member organizations have launched a multi-cancer early detection (MCED) test pilot project. NEHI applies our research on MCED benefit-risk assessment to this initiative.
Posted on January 13, 2022
As we enter a new year and the pandemic continues to challenge us individually and collectively, the need for innovations cannot be overstated. At NEHI, we continue to work to advance innovations that address unmet needs and improve health with an increased focus on three priority areas.
Posted on October 20, 2021
Watch NEHI's Policy and Research Director, Tom Hubbard, speak at the Rhode Island Business Group on Health's webinar on chronic disease.
Posted on September 28, 2021
We mourn the recent passing of Sam Nussbaum, a founder, long-time Board member, and wonderful friend of NEHI.
We are honored and grateful to have experienced his dedication, intelligence, and generosity.
Posted on July 15, 2021
Summary and additional resources from our July 14 discussion webinar 'Psychedelic Medicine: Old Compounds, New Beginnings.'
Posted on June 22, 2021
Summary and next steps from ‘Innovations in Automation of Prior Authorization: Tackling the Issues from a Multi-Stakeholder Perspective' webinar on June 7, 2021.
Posted on June 18, 2021
What we’re thinking about at NEHI: two-way communication between patient communities and health care payers when new, novel and very challenging therapies are approved by the FDA.
Posted on June 17, 2021
Additional resources and summary from May 20 discussion on integrating behavioral health.